{"denoms":[{"counts":[{"groupId":"OG000","value":"0"}],"units":"Participants"}],"groups":[{"description":"The patients will receive Bortezomib on days 1, 4, 8 and 11 of each 21 day cycle in combination with daily oral Thalidomide.\n\nbortezomib\n\nthalidomide","id":"OG000","title":"Bortezomib and Thalidomide"}],"populationDescription":"Analysis not completed as the information was not relevant since no patients went on to transplant.","reportingStatus":"POSTED","timeFrame":"1-6 months","title":"Mobilization of Stem Cells in Patients Proceeding to Autologous Peripheral Stem Transplantation","type":"SECONDARY"}